• 1. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 2. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 3. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Benzodiazole-5-carboxylic acid HCl (CAS No. 1158444-99-5): A Comprehensive Overview

Benzodiazole-5-carboxylic acid HCl (CAS No. 1158444-99-5) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique benzodiazole core and carboxylic acid functionality, has shown promise in various applications, including as a building block for the synthesis of bioactive molecules and as a potential therapeutic agent.

The benzodiazole scaffold is well-known for its pharmacological properties, particularly in the central nervous system (CNS). Compounds derived from this scaffold have been extensively studied for their anxiolytic, sedative, and anticonvulsant effects. The addition of a carboxylic acid group to the benzodiazole ring, as seen in benzodiazole-5-carboxylic acid HCl, introduces new opportunities for functionalization and derivatization, enhancing its potential for drug discovery and development.

Recent studies have highlighted the importance of benzodiazole-5-carboxylic acid HCl in the synthesis of novel compounds with diverse biological activities. For instance, a 2022 study published in the Journal of Medicinal Chemistry reported the use of this compound as a key intermediate in the synthesis of potent inhibitors of protein-protein interactions (PPIs). These inhibitors have shown promise in treating various diseases, including cancer and neurodegenerative disorders.

The chemical structure of benzodiazole-5-carboxylic acid HCl is characterized by a benzene ring fused with a diazole ring, with a carboxylic acid group attached at the 5-position. The presence of the carboxylic acid group provides multiple points for chemical modification, allowing researchers to tailor the compound's properties for specific applications. This flexibility has made it an attractive starting material for the development of new drugs and therapeutic agents.

In addition to its role as a synthetic intermediate, benzodiazole-5-carboxylic acid HCl has been investigated for its own biological activities. Preliminary studies have shown that it exhibits moderate anti-inflammatory and antioxidant properties. These findings suggest that the compound may have potential applications in treating inflammatory diseases and conditions associated with oxidative stress.

The synthesis of benzodiazole-5-carboxylic acid HCl typically involves multi-step processes, including condensation reactions and functional group transformations. One common synthetic route involves the reaction of 2-aminothiophenol with an appropriate carboxylic acid chloride, followed by cyclization to form the benzodiazole ring. The final step involves hydrolysis to introduce the carboxylic acid group and subsequent treatment with hydrochloric acid to form the hydrochloride salt.

The physical and chemical properties of benzodiazole-5-carboxylic acid HCl are well-documented. It is a white crystalline solid that is soluble in water and polar organic solvents such as methanol and dimethyl sulfoxide (DMSO). Its solubility profile makes it suitable for use in various biological assays and chemical reactions.

In terms of safety, while specific handling guidelines may vary depending on the application, general precautions should be taken when working with this compound. It is advisable to handle it in a well-ventilated area and to use appropriate personal protective equipment (PPE) such as gloves and safety goggles.

The future prospects for benzodiazole-5-carboxylic acid HCl are promising. Ongoing research continues to explore its potential applications in drug discovery, particularly in areas such as cancer therapy, neurodegenerative diseases, and inflammatory conditions. Additionally, its use as a building block for more complex molecules opens up new avenues for synthetic chemistry and medicinal research.

In conclusion, Benzodiazole-5-carboxylic acid HCl (CAS No. 1158444-99-5) is a valuable compound with a wide range of applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and versatile reactivity make it an attractive candidate for further investigation and development into novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)